GlassScriptPhysician profile
Eileen Delacova
NPI 1558448613
$2,615.70
in general payments reported to CMS, 2019-2025
21 companies · $742 in 2025
The $742 reported for 2025 was more than what 80% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $464 · 2022: $286 · 2023: $480 · 2024: $643 · 2025: $742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,865.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $875.52 | 2021-2025 | Xtampza, Belbuca |
| Medtronic, INC. | $412.99 | 2021-2025 | Intellis Adaptivestim, Accurian, Inceptiv |
| Abbvie INC. | $251.46 | 2021-2025 | |
| Protega Pharmaceutials INC | $236.73 | 2024-2025 | Roxybond |
| Averitas Pharma INC. | $121.59 | 2023-2025 | Qutenza |
| Tersera Therapeutics LLC | $97.24 | 2025 | Prialt |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.49 | 2021-2025 | Relistor |
| Boston Scientific Corporation | $65.05 | 2021-2022 | |
| Saluda Medical Americas, INC. | $62.16 | 2025 | Evoke |
| Abbott Laboratories | $57.87 | 2021-2023 | Proclaim |
| Biodelivery Sciences International, INC. | $51.13 | 2021 | |
| Allergan, INC. | $50.75 | 2021-2022 | |
| Valinor Pharma, LLC | $50.26 | 2024 | Movantik |
| Biotronik Nro, INC. | $49.11 | 2025 | Prospera |
| Bioventus LLC | $37.13 | 2024 | Gelsyn-3 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $30.23 | 2023 | Seglentis |
| Nevro Corp. | $24.58 | 2021 | |
| Grt US Holding, INC. | $21.42 | 2021 | |
| Redhill Biopharma INC. | $19.91 | 2022 | |
| Innovation Technologies INC | $17.03 | 2025 | Irrisept |
| Vertex Pharmaceuticals Incorporated | $14.05 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eileen Delacova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.